Glucosinolate Derivatives: Emerging Anti-Inflammatory Agents
Pharmaceuticals · 22.04.2026 · 19 (5) · 658
DOI: 10.3390/ph19050658 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 22.04.2026. Verfasst von Sandrine Ressurreição und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Coimbra, Faculty of Pharmacy, 3000-548 Coimbra, Portugal. Die Arbeit nennt 270 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology (FCT/MCTES), European Union's Horizon Europe programme project, European Union’s Horizon Europe programme project.
Abstract (Originalsprache)
Glucosinolates are sulfur-containing secondary metabolites predominantly found in Brassicaceae plants, which, upon enzymatic hydrolysis, generate bioactive compounds with potent anti-inflammatory properties. These derivatives modulate key inflammatory pathways by inhibiting NF-κB nuclear translocation, reducing pro-inflammatory cytokine production, including TNF-α, IL-6, and IL-1β, and suppressing iNOS and COX-2 expressions. They also activate NRF2-dependent antioxidant defenses, upregulating enzymes such as HO-1 and NQO1, and regulate MMPs, contributing to tissue protection during chronic inflammation. Evidence from in vitro and in vivo studies consistently demonstrates their ability to attenuate inflammation and oxidative stress. Although approximately 137 glucosinolates have been identified, only about twelve have been investigated in detail regarding the anti-inflammatory activity of their derivatives, highlighting a significant gap in current knowledge and considerable potential for the discovery of new therapeutic compounds. In this context, a systematic survey was conducted of plant species reported in scientific literature as sources of glucosinolates, with particular emphasis on studies evaluating their extracts and fractions for anti-inflammatory potential in in vitro and in vivo experimental models. Additionally, this review also aims to highlight the anti-inflammatory and antioxidant potential of glucosinolate-derived compounds, focusing on their modulation of the NF-κB and NRF2 signaling pathways and their ability to regulate matrix metalloproteinases. It also emphasizes that, despite the broad diversity of glucosinolates identified to date, only a limited number have been functionally investigated. By addressing this gap, and based on the systematic survey performed, this review underscores the need for further research to fully explore their therapeutic potential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Coimbra, Faculty of Pharmacy, 3000-548 Coimbra, Portugal.
- Polytechnic University of Coimbra, Coimbra Agriculture School, 3045-601 Coimbra, Portugal.
- Chemical Engineering and Renewable Resources for Sustainability (CERES), University of Coimbra, 3030-790 Coimbra, Portugal.
- Center for Innovative Biomedicine and Biotechnology (CIBB)/Center for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504 Coimbra, Portugal.
- Associated Laboratory for Green Chemistry (LAQV) of the Network of Chemistry and Technology (REQUIMTE), University of Coimbra, 3000-548 Coimbra, Portugal.
ORCID-Profile: Sandrine Ressurreição, Sónia A Pinho, Maria Teresa Cruz, Lígia Salgueiro, Artur Figueirinha
Förderung
- Foundation for Science and Technology (FCT/MCTES)
- European Union's Horizon Europe programme project
- European Union’s Horizon Europe programme project
Zitieren
APA
Ressurreição, S., Pinho, S. A., Cruz, M. T., Salgueiro, L., & Figueirinha, A. (2026). Glucosinolate Derivatives: Emerging Anti-Inflammatory Agents. Pharmaceuticals, 19(5), 658. https://doi.org/10.3390/ph19050658
Vancouver
Ressurreição S, Pinho SA, Cruz MT, Salgueiro L, Figueirinha A. Glucosinolate Derivatives: Emerging Anti-Inflammatory Agents. Pharmaceuticals. 2026;19(5):658. doi:10.3390/ph19050658
BibTeX
@article{Ressurreio2026,
author = {Ressurreição, Sandrine and Pinho, Sónia A and Cruz, Maria Teresa and Salgueiro, Lígia and Figueirinha, Artur},
title = {Glucosinolate Derivatives: Emerging Anti-Inflammatory Agents},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {5},
pages = {658},
doi = {10.3390/ph19050658}
}
EUVIMED